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Abstract
Background: Epithelial-mesenchymal cross talk is centerpiece in the development of many branched organs,
including the lungs. The embryonic lung mesoderm provides instructional information not only for lung architectural
development, but also for patterning, commitment and differentiation of its many highly specialized cell types. The
mesoderm also serves as a reservoir of progenitors for generation of differentiated mesenchymal cell types that include
αSMA-expressing fibroblasts, lipofibroblasts, endothelial cells and others. Transforming Growth Factor β (TGFβ) is a key
signaling pathway in epithelial-mesenchymal cross talk. Using a cre-loxP approach we have elucidated the role of the
TGFβ type I receptor tyrosine kinase, ALK5, in epithelial-mesenchymal cross talk during lung morphogenesis.
Results: Targeted early inactivation of Alk5 in mesodermal progenitors caused abnormal development and maturation
of the lung that included reduced physical size of the sub-mesothelial mesoderm, an established source of specific
mesodermal progenitors. Abrogation of mesodermal ALK5-mediated signaling also inhibited differentiation of cell
populations in the epithelial and endothelial lineages. Importantly, Alk5 mutant lungs contained a reduced number of
αSMApos cells and correspondingly increased lipofibroblasts. Elucidation of the underlying mechanisms revealed that
through direct and indirect modulation of target signaling pathways and transcription factors, including PDGFRα,
PPARγ, PRRX1, and ZFP423, ALK5-mediated TGFβ controls a process that regulates the commitment and differentiation
of αSMApos versus lipofibroblast cell populations during lung development.
Conclusion: ALK5-mediated TGFβ signaling controls an early pathway that regulates the commitment and
differentiation of αSMApos versus LIF cell lineages during lung development.
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Background
In mammals, the anterior foregut invades the surround-
ing splanchnic mesoderm to form the primordial lung.
During embryogenesis, this bilayered structure under-
goes a series of highly orchestrated morphogenetic steps
to form a complex respiratory organ purported to in-
clude over 40 specialized cell varieties. Elucidating the
mechanisms that govern commitment and differenti-
ation of these cell types has been a major challenge. The
bulk of the cell types studied has been of endodermal
origin. Much less is known about the regulatory
mechanisms that control the ontogeny and differenti-
ation of the mesodermally-derived cell varieties.
In very broad terms, the lung mesenchyme can be di-
vided into two histologically distinct cell populations
that are detectable as early as E13.5 [1]. The ‘sub-epithe-
lial mesenchymal’ cells wrap around the epithelial ducts,
while the ‘sub-mesothelial mesenchymal’ (SMM) cells
inhabit the area between the mesothelium and the sub-
epithelial mesenchymal cells [1, 2]. SMM is a major site
of Fgf10 expression. We and others have shown that
Fgf10pos cells contribute, but are not the sole source of
smooth muscle (SM) cells and lipofibroblasts (LIFs) [2, 3].
Viewed from the perspective of gene expression, mesoder-
mal derivatives can be simply grouped into two molecu-
larly defined cell populations; the αSMApos and αSMAneg
groups. The primary αSMApos group comprises the fibro-
blasts in the peribronchial (airway) and perivascular SM
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layers as well as interstitial αSMApos myofibroblasts. Not-
ably, the latter cells attain αSMApos status at different
times during lung development. While airway and perivas-
cular SM cells are αSMApos as early as E11.5, interstitial fi-
broblasts begin to display αSMA only in mid to late
gestation. With that caveat in mind, in the present study
we have opted to use the term ‘αSMApos cells’ in a ‘broad
stroke’ to conveniently refer collectively to all cells that ex-
press this marker and not solely the ‘interstitial myofibro-
blasts’ noted routinely by other investigators.
Generation of mesodermal cell diversity occurs con-
currently with the structural development of the lung. A
central player is the reciprocal communication known as
epithelial-mesenchymal interactions that occur between
the foregut endoderm and the lateral plate mesoderm-
derived splanchnic mesenchyme. This process works on
a ‘signaling, transcription factors, signaling’ algorithm
[4–6]. Additional integral components include the extra-
cellular matrix, structural proteins and differentiation-
specific proteins. A major signaling pathway in the lung
and other mammalian organs is the transforming growth
factor beta (TGFβ) family of secreted polypeptides.
The significance of TGFβ signaling during develop-
ment and disease can be hardly overstated. TGFβ is the
prototype of a family of secreted dimeric peptide growth
factors that includes the TGFβs, activins, inhibins, and
bone morphogenetic proteins [7]. In vertebrates, TGFβ
regulates key processes in stem cell maintenance, or-
ganogenesis, wound healing, and homeostasis. Given this
broad range of activity, it is not surprising that TGFβ
dysregulation results in a spectrum of pathologies ran-
ging from cancer to pulmonary fibrosis.
The TGFβ machinery has many "moving parts. The li-
gands are produced as ‘latent’ peptides. Upon secretion
and activation, all three TGFβs signal by engaging a spe-
cific receptor, composed of two related transmembrane
serine/threonine kinases, called the type I and type II
TGFβ receptors (TβR1, or ALK5 and TβR2) [8]. The
basic mechanism of receptor activation involves binding
of the ligand to TβR2, followed by recruitment of ALK5.
Recruitment triggers ALK5 kinase activity, transducing
the signal by phosphorylating and activating members of
the SMAD family of transcription factors [8].
In various tissues, TGFβ response is remarkably cell
type and context dependent. It is equally true that the
downstream effects of TGFβ are transduced not simply
via a single target, but may involve multiple nodes.
Given the multicomponent nature of the pathway, there
is a wide spectrum of versatility and selectivity in TGFβ
biologic functions. Some are ostensibly paradoxical. For
example, TGFβ acts as both a cancer promoter and
suppressor [9]. Selective utilization of receptors is a po-
tential mechanism for generating versatility in TGFβ
function. TGFβ expression is thought to be ubiquitous
throughout the lung with both endodermal and meso-
dermal cells displaying ALK5 and TβR2. Elucidating the
function of each receptor in specific cell types and in
particular in endodermal versus mesodermal cells of the
lung is a necessary step towards unlocking the precise
roles of TGFβ in development and disease. Attempts to
define the specific role played by each of the receptors
using targeted germline deletions of either Tβr2 or Alk5
have not been fully successful due to early embryonic
lethality [10, 11]. Using conditional inactivation, we have
shown that lack of mesodermal-specific TβR2 causes
embryonic lethality, while endodermal Tβr2 inactivation
is not only tolerated and viable, but protects against ex-
perimentally induced fibrosis and bronchopulmonary
dysplasia [12, 13]. A systematic approach involving abro-
gation of each receptor on a cell-type specific basis has
the promise of revealing the precise roles of each recep-
tor during embryonic development.
In this study, Alk5 was specifically inactivated in the
early embryonic multipotential mesoderm that is the ori-
gin of lung mesodermal progenitors. Alk5Dermo1 mice
displayed multiple abnormalities and postnatal lethality.
Their lungs were structurally immature (pulmonary
hypoplasia), characterized by thickened mesenchymal
walls around significantly reduced alveolar spaces. Im-
portantly, the studies revealed a novel role for ALK5-
mediated TGFβ signaling that regulates the balance
between αSMApos and LIF cell fate commitment and dif-
ferentiation during lung development. The precise bal-
ance between these key cell populations is critical to
normal lung development and its disruption underlies
the pathobiology of serious pulmonary disorders.
Results
Mesodermal-specific Alk5 inactivation
The localization and efficiency of LoxP-dependent ex-
cision in Dermo1-cre (aka, Twist2-cre) mouse lungs
has been previously reported [14, 15]. Dermo1-driven,
Cre-mediated recombination occurs early and exclu-
sively throughout the tracheal and pulmonary meso-
derm, but not in the epithelium (Additional file 1A–C).
Accordingly, we generated triple transgenic Dermo1-
cre;Alk5flox/flox;mTmG mice (Methods) in which exon 3
of the Alk5 gene is excised in early pulmonary mesoder-
mal progenitors (Additional file 1D). Over 800 fetuses at
various embryonic stages were genotyped and analyzed
(Additional file 1E).
Heterozygous Alk5flox/wt;Dermo1-Cre;mTmG mice were
born alive and had no discernable abnormalities in
development, growth, or reproduction. Homozygous
Alk5flox/flox;Dermo1-Cre;mTmG (hereafter Alk5Dermo1)
embryos examined at E11.5 showed no obvious mor-
phological defects. Defects in body-wall closure in
Alk5Dermo1 embryos, as previously reported [16], were
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evident at E12.5 (data not shown). Embryonic lethality
occurred between E14.5 and E18.5. Occasionally, mu-
tant embryos with a less severe phenotype survived to
birth but died immediately afterwards.
To confirm deletion of Alk5 from the pulmonary meso-
derm, expression of ALK5, phospho-SMAD2 (p-SMAD2),
and PAI-1 were assessed by immunoblotting. The latter is
expressed by mesenchymal cells in response to canonical
TGFβ signaling. Compared to controls, ALK5 was de-
creased by nearly 85 % (0.15 ± 0.013), p-SMAD2 by
73 % (0.23 ± 0.02), and PAI-1 expression reduced by
83 % (0.17 ± 0.05) (Additional file 1F). Immunohisto-
chemistry (IHC) for ALK5 and PAI-1 on E15.5 lung
sections confirmed decreased mesenchymal and intact
epithelial ALK5 immunoreactivity (Additional file 1G–J).
While these results confirm abrogation of canonical TGFβ
signaling, the source of the residual activity can be cer-
tainly attributed to intact signaling in the lung epithelium.
Lung immaturity and blocked epithelial and endothelial
cell differentiation in Alk5Dermo1 lungs
The lungs of E18.5, Alk5Dermo1 embryos were smaller
and poorly expanded, but the number of lobes appeared
normal (Additional file 2A–D and data not shown). The
alveolar diameters were decreased and septal thicknesses
increased relative to control lungs (Additional file 2E–J).
Glycogen stores, which are an epithelial marker of im-
mature lungs [17], were also increased in Alk5Dermo1
lungs (Additional file 2G,J). IHC using antibodies
against acetylated tubulin, CC10, pro-SPC, and T1a
(specific to ciliated cells, Clara cells, alveolar epithelial
type II cells, and alveolar epithelial type 1 cells,
respectively) showed reduced differentiation of all four
major epithelial cell types in E18.5 Alk5Dermo1 lungs
(Additional file 3A–H). These findings were also ex-
amined by quantitative PCR (Q-PCR) (Additional file 3I).
Cumulatively, these results suggest that lung maturation
and epithelial cell differentiation are delayed by mesenchy-
mal Alk5 inactivation.
The lung mesoderm serves as the origin of endothelial
cells that form the pulmonary vasculature. Flk1,
expressed by vascular endothelial progenitors, was re-
duced in E13.5 Alk5Dermo1 lungs as was the fraction of
CD34pos cells (Additional file 3J–M). As lung develop-
ment progressed, PECAM1, a vascular endothelial dif-
ferentiation marker, was also reduced. The distal
capillary plexus adjacent to the airway epithelium was
less dense compared to age-matched controls (Additional
file 3N–Q). However, the large blood vessels were intact
(Additional file 3P,Q, Arrows). Q-PCR of multiple vascular
markers showed that in Alk5Dermo1 lungs, Pecam-1 mRNA
was 0.58 ± 0.19 (P <0.05), Flk1 was 0.63 ± 0.18 (P <0.05),
and Flt-1was 0.67 ± 0.15 (P <0.05) of controls (Additional
file 3R). However, mutant and control lungs had similar
Flt-4 (0.83 ± 0.23, P >0.05) and Vegfa (0.78 ± 0.23, P >0.05)
mRNAs.
Mesodermal-specific Alk5 inactivation reduces the
sub-mesothelial mesenchyme
Structurally, the SMM [15] of Alk5Dermo1 lungs was
smaller and more irregularly shaped compared to
control lungs (Fig. 1a–e and Additional file 4). Anti-
phospho-histone H3 labeling revealed fewer mitotic
cells within the distal mesenchyme of mutant lungs
(2.02 % vs. 0.6 %). The SMM regulates epithelial,
smooth muscle, and vascular development by produ-
cing factors such as FGF10 [18]. FGF10 mRNA in
mutant lungs was 0.63 ± 0.02 of controls (Fig. 1g). In
addition, Fgf9 made by the mesothelium/epithelium
and Fgf7 expressed by the mesenchyme were respectively
expressed at 0.84 ± 0.04 and 0.58 ± 0.05 of controls
(Fig. 1g). To assess the functional significance of the re-
duced Fgf10 and Fgf9 mRNAs, we examined expression of
their target genes. Immunoblotting revealed decreased
SPRY2 and SPRY4 in Alk5Dermo1 lungs relative to controls,
confirming functionally reduced FGF10 signaling (Fig. 1h).
Similarly, there was profound decrease in the homeodo-
main transcription factor PITX2, a major target of FGF9
(Fig. 1h). These data suggest that mesodermal Alk5 inacti-
vation reduces SMM volume by decreasing overall func-
tional FGF signaling.
Inhibition of airway smooth muscle development
FGF10pos cells contribute to differentiated peribronchial
smooth muscle (PBSM) cells [3]. By IHC, layers of
αSMApos PBSM were thinner in diameter and included
large gaps in E18.5 mutant lungs (Fig. 2a–h). However,
αSMA expression around large blood vessels was similar
in mutant and control lungs (Fig. 2f, Arrowheads). Con-
sistent with the IHC, Q-PCR showed reduced mRNA for
multiple myofibroblast markers in Alk5Dermo1 lungs
(Fig. 2i). These included αSMA (0.56 ± 0.85), Calponin
(0.67 ± 0.016), SM-MHC (0.63 ± 0.016), and SM22α
(0.71 ± 0.18). In addition, there was reduced mRNA for
both Pdgfrα (0.45 ± 0.021) and Pdgfrβ (0.625 ± 0.073).
Transcripts for NOGGIN, an airway smooth muscle cell
marker [19, 20], were also decreased (Fig. 2j, 0.39 ± 0.1
of controls, P <0.05) while those for Heyl, a vascular
smooth muscle marker [20, 21], were only slightly re-
duced (Fig. 2j, 0.71 ± 0.078 of controls, P <0.05). Thus,
the diminished αSMApos cells in Alk5Dermo1 lungs were
primarily lost from the PBSM layers. In addition, there
was decreased mRNA for paired-homeobox transcrip-
tion factor PRRX1 (0.7 ± 0.056 of controls, P <0.05) and
the extracellular matrix glycoprotein TENASCIN-C
(TNC; 0.53 ± 0.047 of controls, P <0.01), both of which
promote myofibroblast growth and differentiation
(Fig. 2k). The effects of ALK5 abrogation on αSMApos
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cell commitment was also assessed by analysis of
PDGFRα protein (Fig. 3a–f ), which is regulated by TNC
and highly expressed on αSMApos cell precursors [22].
The fraction of PDGFRαpos cells surrounding the airway
epithelium was significantly reduced in Alk5Dermo1 lungs
(Fig. 3d–f ), and western blot analysis confirmed the de-
crease in αSMA and PDGFRα (Fig. 3g, i). Consistent
with this observation, phosphorylation of AKT, the ca-
nonical substrate of PDGFA-activated PDGFRα [23–25],
was reduced in both Alk5Dermo1 lung homogenates
(Fig. 3g) and isolated primary Alk5Dermo1 mesenchymal
cells (Fig. 3h). Thus, ALK5-mediated TGFβ signaling is
required in lung αSMApos cell development, and early
defects in this pathway lead to decreased populations of
cells expressing αSMA or PDGFRα.
Lipofibroblast (LIF) hyperplasia in Alk5Dermo1 lungs
In addition to αSMApos and endothelial cells, the multi-
potential lung mesoderm gives rise to LIFs. In the rat,
LIFs are detected on embryonic day E16, increase during
gestation, and decline after birth [26]. Oil Red O staining
of Alk5Dermo1 lungs revealed overwhelmingly abundant
LIFs within the developing mesoderm, relative to con-
trols (Fig. 4a–d and Additional file 5). To confirm that
observation, Q-PCR was used to quantify the mRNA for
multiple LIF markers, including adipocyte transcription
factors PPARγ and CEBPα, the lipid droplet-associated
Adipose Differentiation-Related Protein (ADRP), and
adipocyte Fatty Acid Binding Protein 4 (FABP4). All
were elevated in Alk5Dermo1 lungs (Fig. 4e). Immunoblots
of total Alk5Dermo1 lung homogenates confirmed that
ADRP, CEBPα, and PPARγ proteins were more abundant
compared to controls. Furthermore, p-AKT and p-ERK
were decreased while PTEN, a TGFβ-repressed phos-
phatase associated with LIF hyperplasia [27], was in-
creased in Alk5Dermo1 lungs (Fig. 4f ). Importantly,
Zfp423, which encodes a zinc finger transcription factor
that regulates PPARγ in pre-adipocytes [28, 29], as well
as WISP2, a matricellular protein that is highly
expressed in adipocyte precursors [30, 31], were in-
creased in Alk5Dermo1 lungs (Fig. 4g). These findings
indicate that abrogation of ALK5-mediated signaling
increases LIF commitment and differentiation.
Establishment of Alk5-deficient mesodermal cell lines
The aggregate data presented above suggests that in-
activation of Alk5 in multipotential lung mesoderm
promotes LIF commitment and inhibits SM differenti-
ation. To examine the underlying mechanisms, we
isolated mesodermal cells from Alk5Dermo1;mTmG and
Alk5flox/flox;mTmG mouse lungs. These Alk5–/– and
Alk5+/+cells were immortalized by transfection with
an SV40 plasmid and purified by FACS (Methods).
TGFβ-induced SMAD2 phosphorylation was nearly
absent in Alk5–/– cells, confirming abrogation of






Fig. 1 Mesodermal progenitor-specific deletion of Alk5 reduced the sub-mesothelial mesenchyme. (a–f) Gross morphology (a, d, b, and e) and
hematoxylin and eosin staining (c and f) show decreased sub-mesothelial mesenchyme in Alk5Dermo1 mutant lungs at E12.5 (b, e, c, and f) or
E13.5 (a and d). (g) Quantitative PCR showed decreased Fgf 7, Fgf9, and Fgf10 mRNA in E13.5 Alk5Dermo1 lungs; n = 2 controls and 3 mutant lungs.
(h) Western blot analysis showed decreased FGF signaling target genes. β-ACTIN was used as control, n = 3. Error bars show standard deviation.
Scale bar: f = 20 μm
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Other mediators of TGFβ signaling were also affected.
Baseline p-P38, p-AKT and p-ERK were high in Alk5+/+
control cells but TGFβ stimulation minimally induced p38
activation in mutant cells. TGFβ also had little impact on
p-AKT in the mutant cells, but total AKT was reduced.
Importantly, baseline ERK phosphorylation was elevated
in Alk5–/– cells, and TGFβ induced a robust response in
these cells compared to Alk5+/+ controls (Fig. 5a). These
findings indicate the critical and complex role of ALK5
activity in the TGFβ signal transduction pathway.
ALK5-mediated TGFβ represses the LIF transcription
factor ZFP423 in vitro
We also evaluated the impact of TGFβ on the isolated
cells. Treatment with recombinant TGFβ (4 ng/mL for
48 hours, Materials & Methods) initiated myogenic dif-
ferentiation as assessed by increased αSMA and Prrx1
transcripts in Alk5+/+ but not Alk5–/– mesenchymal cells
(Fig. 5b–f ). In contrast, Tnc induction by TGFβ was
unaffected by Alk5 inactivation, suggesting that its regu-
lation is independent of ALK5 and the canonical TGFβ
pathway. Conversely, Alk5–/– cells displayed a signifi-
cantly high rate of spontaneous adipogenic differenti-
ation in non-induced, minimum standard culture
medium (Fig. 5g, h). This did not occur in Alk5+/+ con-
trols, and was verified by assessing the expression of
adipogenic markers. After 5 days in culture, lipogenic
mediators, including Adrp, Cebpα and Pparγ mRNA, in-
creased by 1.57 ± 0.34-, 3.02 ± 0.7-, and 3.57 ± 1.1-fold,
respectively in the Alk5–/– cells compared to 3.95 ± 0.68-,
4.4 ± 1.0-, and 8.58 ± 2.1-fold in the Alk5+/+cells (Fig. 5i).
Likewise, Zfp423 mRNA was 11-fold higher and Wisp2
mRNA was 17-fold higher in Alk5–/–cells relative to
Alk5+/+ cells (Fig. 5j). To determine the relationship
between TGFβ and Zfp423, we treated Alk5+/+ and











Fig. 2 Mesodermal Alk5 deficiency inhibits smooth muscle development. (a–h) Immunohistochemistry (IHC) showed αSMA is decreased throughout
lung development in Alk5Dermo1 lungs. (i) Quantitative PCR (Q-PCR) confirmed the repression of myofibroblast-related mRNAs in Alk5Dermo1 lungs at
E13.5. n = 2 pairs of separate lungs, repeated once. (j) Q-PCR analysis showed decreased Noggin with smaller loss in Heyl expression in Alk5Dermo1 lungs
at E13.5. n = 3 pairs of separate lungs. (k) Q-PCR showed decreased Tnc and Prrx1 mRNA in Alk5Dermo1 lungs. n = 3 pairs of separate lungs. Error bars
show standard deviation. *P <0.05. Scale bar: h = 20 μm






Fig. 3 Mesodermal Alk5 deficiency reduces smooth muscle precursors. (a–f) Immunohistochemistry showed reduced αSMA (green) and PDGFRα
(red) in Alk5Dermo1 lungs throughout lung development. (g) Western blot analysis showed decreased αSMA, PDGFRα and p-AKT protein in E15.5
Alk5Dermo1 whole lung tissue. β-ACTIN was used as control. n = 3 separate lungs. (h) Western blot analysis showed decreased p-AKT protein in
primary mesenchymal cells isolated from E15.5 Alk5Dermo1 lungs. n = 3 pairs of separate lungs. β-ACTIN was used as control. (i) Densitometric





Fig. 4 Lipofibroblast hyperplasia in Alk5Dermo1 lungs. (a–d) Oil Red O-stained cells are increased in E18.5 Alk5Dermo1 lungs. Dotted lines indicate
basement membrane between epithelium and surrounding mesenchyme. (e) Quantitative PCR (Q-PCR) showed mRNA for LIF markers increased
in E18.5 Alk5Dermo1 lungs. n = 3 pairs of independent lungs, Error bars show standard deviation, *P <0.05. (f) Western blot analysis confirmed
increased LIF markers, n = 6 pairs of lungs. Western blot analysis also showed decreased p-AKT and p-ERK, and increased PTEN. β-ACTIN was
used as control. n = 3 pairs of lungs. (g) Q-PCR showed increased Zfp423 and Wisp2 mRNA in Alk5Dermo1 lungs compared to controls. n = 5–6
pairs of independent lungs. Error bars show standard error of the mean. *P <0.05. Scale bar: d = 10 μm
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for 48 hours, Materials & Methods). Controls were
treated exactly the same with the exception of bovine
serum albumin (BSA) replacing TGFβ. TGFβ repressed
Zfp423 mRNA levels and this activity was dependent on
ALK5 (Fig. 5k, l). Taken together, these data indicate a
novel mechanism by which abrogation of ALK5-mediated
canonical TGFβ signaling, through regulation of Zfp423,
promotes LIF versus αSMApos cell differentiation in lung
mesodermal cells.
The role of PDGFRα
As noted above, PDGFRα and signaling were decreased
in Alk5Dermo1 lungs (Fig. 3). Although PDGFRαpos cells
can differentiate into either αSMApos cells or LIFs, their
role in determining mesodermal commitment has not
been elucidated. We therefore sought to determine
whether PDGFA signaling through PDGFRα is necessary
for Alk5 to induce αSMApos cell differentiation. TGFβ is
known to induce Pdgfrβ; however, its role in regulating
Pdgfrα remains unknown. Because PDGFRα is decreased
in Alk5Dermo1 mutant lungs, its possible regulation by
TGFβ was evaluated by TGFβ treatment (4 ng/mL,
Materials & Methods) for 48 hours. Controls were
treated exactly the same with the exception of BSA re-
placing TGFβ. TGFβ increased both Pdgfrα and Pdgfrβ
mRNAs in Alk5+/+ cells but not in Alk5–/– cells (Fig. 6a)
indicating that TGFβ regulation of Pdgfrα and, hence,
αSMApos cell differentiation, requires ALK5 activity. Sur-
prisingly, Pdgfrα mRNA increased during spontaneous
differentiation of Alk5–/– cells to LIFs over a 5 day
period (Fig. 6b). In addition, PDGFRα protein was con-
sistently higher in Alk5–/– compared to Alk5+/+ cells on
Fig. 5 Reduced myogenesis and increased adipogenesis in SV40-trasformed, GFP-sorted Alk5–/– cells. (a) Western blot analysis of major signaling
pathway components in SV40-trasformed and GFP sorted Alk5+/+ and Alk5–/– cells treated with or without TGFβ1, n = 3 cell isolations from 6 pairs
of lungs were used for each condition. (b–e) Representative images of Alk5+/+ and Alk5–/– cells treated with (c and e) or without (b and d) TGFβ1
for 48 hrs. Note the morphology difference between Alk5+/+ and Alk5–/– treated with TGFβ1 (c vs. e). (f) Quantitative PCR (Q-PCR) of mRNA
isolated immediately after 48 hours of TGFβ treatment showed induced αSMA and Prrx1 mRNA by TGFβ1 only in Alk5+/+ cells, while Tnc
mRNA was induced in both Alk5+/+ and Alk5–/– cells. n = 2–3 cell isolations from 6 pairs of lungs per experiment, repeated once for each.
(g and h) Oil Red O staining showed lipofibroblasts (LIFs) increased extensively in Alk5–/– mesenchymal cells, cultured in 2 % low serum for
5 days. (i) Q-PCR showed increased LIF-related gene expression in Alk5–/– cells cultured for 5 days. n = 4 cell isolations from 6 pairs of lungs
per experiment, repeated 2 to 3 times. (j) Q-PCR showed increased Zfp423 and Wisp2 mRNA in Alk5–/– cells. n = 5 to 6 cell isolations from 6 pairs
of lungs per experiment, repeated 1 to 4 times. k. Gel image of Q-PCR products quantified in (l) of Zfp423 mRNA in Alk5+/+ and Alk5–/– cells,
treated with or without TGFβ1 for 48 hrs. Zfp423 mRNA was decreased only in the Alk5+/+ cells, treated with TGFβ1. n = 2 cell isolations from 6
pairs of lungs per experiment, repeated once for each. Error bars show standard error of the mean except for (l) which shows standard
deviation. *P <0.01. Scale bars: e = 20 μm, h = 10 μm
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both day 2 and day 5 of culture (Fig. 6c). These observa-
tions suggest the possibility of alternative or additional
mechanisms that may regulate PDGFRα expression in
these cells.
The need for signaling through PDGFRα during
αSMApos cell differentiation was examined in vitro
and in vivo. Application of the kinase inhibitor Ima-
tinib to Alk5+/+ cells reduced the mRNA for known
PDGFA targets Arid5b, Tiparp, and Schip1 (Fig. 6d),
thereby validating its use. Importantly, Imatinib re-
duced the expression of myogenic markers (Fig. 6e)
but, of the LIF markers, only Pparγ was strongly in-
creased. Adrp was modestly increased by higher Ima-
tinib doses (Fig. 6f ). These results suggest that Pdgfra
inactivation in mesodermal precursors prevents αSMApos
cell differentiation but is insufficient to promote LIF
commitment.
To confirm this finding in vivo, genetically engineered
mice were generated in which Pdgfrα was inactivated in
mesodermal tissues by Dermo1-cre. The resulting
Pdgfrαflox/flox;Dermo1-cre mice (PdgfrαDermo1) survived to
birth at predicted Mendelian ratios but were 22 %
smaller than control littermates (1.45 ± 0.03 g vs.
1.14 ± 0.04 g, P <0.001). PdgfrαDermo1 mutant mice
also developed spina bifida as reported in mice defi-
cient in PDGFRα-stimulated phosphatidyl-inositol 3’
kinase activity [23]. IHC on E18.5 control lungs lo-
calized PDGFRα-expressing cells to the stroma and to
areas surrounding the airways and blood vessels (Fig. 7a).
These cells were absent or significantly reduced in Pdgfra-
Dermo1 lungs (Fig. 7b and Additional file 6). Q-PCR showed
reduced mRNA for PDGFA targets, including Zfand5,
Myo1e, Arid5b, Tiparp, and Schip1 [32], confirming func-







Fig. 6 Role of Pdgfrα. (a) Quantitative PCR (Q-PCR) analysis showed induction (fold increase over controls) of Pdgfrα and Pdgfrβ mRNAs in response to
48 hours of TGFβ1 treatment only in Alk5+/+ cells. Controls were treated exactly the same with the exception of bovine serum albumin in place of
TGFβ. For each condition, the RNA was isolated from combined triplicate wells. For Pdgfrα, n = 2 cell isolations from 6 pairs of lungs per experiment,
repeated 2 to 3 times. For Pdgfrβ, n = 3 cell isolations from 6 pairs of lungs per experiment. All conditions were initiated and analyzed after the same
incubation period. (b) Progressive increase in Pdgfrα and Pdgfrβ mRNAs, without TGFβ1-induction during spontaneous differentiation of Alk5 cell lines
in culture for 0, 2, and 5 days. For each condition, the RNAs were isolated from combined triplicate wells. n = 2 cell isolations from 6 pairs of lungs per
experiment, repeated once for each. In both (a) and (b), RNA was isolated at the indicated time point and Q-PCR was performed immediately after.
Note higher levels in Alk5–/– compared to Alk5+/+ cells on both day 2 and day 5. (c) Western blot analysis confirmed higher PDGFRα protein
in three independent samples of Alk5–/– cells on both day 2 and day 5, compared to Alk5+/+. n = 3 independent experiments. β-ACTIN was
used as a control. (d–f) Alk5+/+ cells were treated with or without Imatinib at 5 μm and 10 μm for 5 days, mRNA for PDGF signaling target
genes (d), myofibroblast-related genes (e) and lipofibroblast-related genes (f) were analyzed by Q-PCR (n = 2 cell isolations from 6 pairs of
lungs per experiment for (d) and n = 3 cell isolations from 6 pairs of lungs per experiment for (e) and (f). Error bars show standard deviation
in (d) and standard error of the means in (e) and (f). *P <0.05
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(Fig. 7c and Additional file 7A). The αSMApos cell layers
in mutant lungs were reproducibly thinner compared to
controls, with gaps in αSMA expression (Fig. 7b, Arrows
and Additional file 6). Q-PCR of E18.5 PdgfraDermo1 lungs
showed decreased mRNA for multiple myofibroblast
markers, including Prrx1 (0.45 ± 0.01 of control), SM22α
(0.75 ± 0.02), and αSMA (0.79 ± 0.03) (Fig. 7d). Myofibro-
blast marker mRNAs were similarly decreased in E14.5
PdgfraDermo1 lungs (Additional file 7B). Similar analysis of
adipogenic-related genes in PdgfraDermo1 lungs at E18.5
showed increased Pparγ mRNA but only modest increases
in Adrp, Fabp4, and Cebpα (Fig. 7e). The balance between
αSMApos cells and LIF phenotypes in PdgfraDermo1 lungs
was less severely distorted than those in Alk5Dermo1 mice.
In sum, these data support a model whereby ALK5-
mediated TGFβ signaling regulates αSMApos versus LIF
cell differentiation only partly through the PDGFA/
PDGFRα pathway and that inhibition of this pathway is
insufficient to promote LIF differentiation.
Discussion and conclusions
The present study provides genetic, histologic, and mo-
lecular evidence that mesodermal inactivation of Alk5 in
the mouse lung restricts αSMApos cell fate and promotes
LIF differentiation. In this context, ALK5 meets the def-
inition of a molecular binary switch that functions in
determination and subsequent specialization of at least
two key lung mesodermal cell lineages.
An early morphological phenotype of Alk5Dermo1 em-
bryonic lungs is the reduced physical size of the SMM.
This was associated with decreased proliferation of the
lung mesoderm and reduction in Fgf9. Fgf9 is expressed
by both the mesothelium and the epithelial layers in the
lung [1, 2]. Dermo1-cre is not known to be active in the
mesothelium, although the origin of some mesothelial
cells may be traced to the pulmonary mesoderm [33].
Whether reduced Fgf9 is due to direct impact of Alk5
inactivation or a result of mesoderm-mesothelial cross
communication remains unknown. FGF9 signaling
through FGFR1 and FGFR2 is both necessary and suffi-
cient for SMM growth. Although Alk5 inactivation
modestly decreased Fgf9, PITX2, a homeodomain tran-
scription factor that is induced by FGF9, was strongly
inhibited (Fig. 1k). SMM volume is profoundly sensitive
to FGF9 signaling, being entirely absent from Fgf9–/–
lungs and enlarged in Fgf9 gain-of-function mutants [1].
The reduced SMM size and mitotic index indicate that
ALK5 is required for either mesothelial Fgf9 expression
or FGF9 responsiveness. Ligand-dependent TβRII signal-
ing has been shown to regulate FGF9- and PITX2-
mediated cell proliferation in the palatal mesenchyme





Fig. 7 Mesodermal progenitor-specific deletion of Pdgfra. (a and b) Immunohistochemistry showed PDGFRα (red) is lost in the lung mesenchyme
and αSMA (green) is decreased in E18.5 PdgfraDermo1 lungs. Arrows indicate gaps in αSMA in mutant lungs. “aw” indicates airway. (c) Quantitative
PCR (Q-PCR) showed a decrease in mRNA for PDGF signaling target genes, indicating an overall functional repression of the signaling pathway in
E18.5 PdgfraDermo1 lungs. n = 2 pairs of separate lungs, repeated once for each. (d) Q-PCR showed myofibroblast-related genes are decreased in
E18.5 PdgfraDermo1 lungs. n = 2 pairs of separate lungs, repeated once. (e) Q-PCR showing only Pparγ is robustly increased among lipofibroblast-
related genes in E18.5 PdgfraDermo1 lungs. n = 2 pairs of separate lungs, repeated once. (f) Schematic model for ALK5 binary switch function in
mesodermal progenitor cell fate determination. TGFβ via ALK5 is a direct activator of Prrx1 (Fig. 5f) a key transcriptional regulator of the αSMApos
cell pathway. TGFβ via ALK5 also directly stimulates Pdgfrα mRNA (Fig. 6a), which further promotes αSMApos cell commitment [22]. PRRX1 and
PDGFRα are reciprocal activators. In the absence of Alk5, Zfp423, which is normally repressed by TGFβ (Fig. 5l) is de-repressed, leading to activation of
Pparγ [28], a transcriptional activator of lipogenic cell commitment. PRRX1 and PDGFRα inhibit adipogenesis by directly repressing PPARγ [44]. Error
bars show standard error of the mean. Scale bar: b = 20 μm
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mediate TGFβ-mediated control of FGF9 signaling
within the SMM.
The Alk5Dermo1 lungs also displayed defective epithelial
differentiation. As Dermo1 is exclusively mesodermal,
the abnormalities in epithelial cell differentiation pre-
sumably represent altered mesenchymal regulation of
epithelial progenitors. Previous studies have suggested
that FGF7, which is reduced in Alk5Dermo1 lungs, partici-
pates in mesenchymal-epithelial cross-talk [2]. Alterna-
tively, TGFβ also regulates epithelial differentiation by
altering the composition of the underlying matrix [35].
Finally, TUNELpos cells were found scattered in the
parenchyma of late stage (i.e. E18.5) Alk5Dermo1 lungs
(Additional file 8). Although these cells are not localized
to the airways, the possibility that some of the changes
in airway gene expression may be due to increased apop-
tosis cannot be presently ruled out.
The loss of Alk5 in mesodermal progenitors also dis-
rupted pulmonary vasculogenesis. Flk1, also known as
vascular endothelial growth factor receptor 2, is
expressed by endothelial progenitors [36] and was
strongly decreased in E13.5 Alk5Dermo1 lungs. This likely
accounts for the simplified vasculature observed in
E18.5 mutant lungs. Since Dermo1 may not be expressed
in endothelial progenitors [37, 38], it is unclear whether
Alk5 directly participates in vascular endothelial cell
commitment. In addition, reduced Fgf9 in Alk5Dermo1
lungs might also contribute to the observed vascular
phenotype. Increased Fgf9 in vivo is sufficient to expand
the network of Tie2-lacZ and PECAMpos cells through
stimulation of undifferentiated mesenchyme and/or vas-
cular progenitor cells [1].
The key finding of the present study is that inactiva-
tion of Alk5 inhibits αSMApos and promotes LIF differ-
entiation, both in vivo and in cultured lung mesodermal
cell lines. Markers of myofibroblast differentiation, in-
cluding αSMA, SM22α, and calponin, were reduced,
while mediators of lipogenic commitment, such as
ADRP, were robustly increased. The mechanism under-
lying this phenotype is complex. Since TGFβ signaling is
known to induce αSMApos cell differentiation, its inhib-
ition is readily explicable by ALK5 deficiency. In
addition, FGF10pos cells are known to contribute to
αSMApos cells during lung development [3]. FGF10
mRNA was reduced as was the physical size of SMM,
the site of FGF10pos cells. In contrast to this finding, we
had previously found increased Fgf10 mRNA and SHH
signaling in mesodermally-targeted TβR2Dermo1 lungs
[39]. The discrepancy between the previous and present
observations on FGF10 provides an excellent illustration
of differential TGFβ signaling via receptor selectivity as
described in the Background section. Thus, receptor se-
lectivity (TβR2 vs. ALK5) represents an important mech-
anism by which TGFβ can impose a vast spectrum of
physiologic changes on different (or same) tissues and
cell types. In the present study, when the observation on
reduced Fgf10 levels in the Alk5Dermo1 lungs is combined
with a diminished mitotic cell index in the SMM com-
partment, the data suggest a decreased number of
FGF10pos cells and hence reduced αSMApos cell differen-
tiation. Consistent with this conclusion, histological ana-
lysis of Alk5Dermo1 lungs revealed reduced αSMApos cell
differentiation in the PBSM but not in perivascular
smooth muscle cells (Fig. 2f ). It is unclear whether
PBSM cells and vascular smooth muscle cells have com-
mon or distinct developmental origins.
PDGFRα is also expressed by αSMApos progenitors
and was similarly and profoundly reduced in Alk5Dermo1
lungs. Its functional abrogation was confirmed by re-
duced phosphorylation of AKT, its principle intracellular
substrate (Fig. 3). Our study showed that the TGFβ-
ALK5 axis regulates Pdgfrα mRNA expression (Fig. 6a).
Therefore, it was surprising to find that Pdgfrα mRNA
increased during spontaneous differentiation of Alk5–/–
cells to LIFs (Fig. 6b). It is likely that in these isolated
cells alternative or additional mechanisms may exist
which regulate Pdgfrα expression, independent of the
TGFβ-ALK5 axis. One potential mechanism may be in-
creased spontaneous phosphorylation of ERK found in
Alk5–/– cells compared to Alk5+/+cells and Alk5Dermo1
lungs (Figs. 4 and 5). The underlying cause of increased
p-ERK in cells lacking ALK5 activity is outside the scope
of the present study, but is being currently investigated
in separate studies. What remains firmly established
from these in vitro studies is that inhibition of PDGFRα
by Imatinib reduced expression of myofibroblast
markers but did not fully promote LIF differentiation; of
the lipogenic genes, only Pparγ was increased. This find-
ing was validated by genetic targeting of Pdgfrα in vivo
(Fig. 7). Inactivation of Pdgfrα in early mesodermal pro-
genitors (PdgfraDermo1) robustly inhibited the expression
of myofibroblast-specific genes (Fig. 7d), while, com-
pared to Alk5Dermo1 lungs, the impact on LIF differenti-
ation was subtle, despite strong activation of Pparγ in
cultured cells. Thus, while PDGFRα is required for full
expression of the myofibroblast-specific gene battery, its
absence is capable of initiating, but not completing, the
LIF differentiation program.
LIFs are critical regulators of alveologenesis and as-
similate and transfer neutral lipids to adjacent type II
cells, thereby facilitating surfactant formation [40]. LIF
commitment may be favored by increased expression of
PTEN, a phosphatase that regulates the fate of mesoder-
mal progenitors (Fig. 4f ). This finding recapitulates our
previous study in which Dermo1-cre-mediated inactiva-
tion of Pten profoundly reduced ADRP [14]. Pten was
originally identified as a negatively regulated target of
TGFβ signaling [41].
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Based on the collective observations in this study we
propose a model whereby multiple signaling pathways,
controlled by ALK5-mediated TGFβ signaling, converge
on transcriptional factors that regulate the cell lineage
determination of two key mesodermal specialized cell
types (Fig. 7f ). The two major transcription factor tar-
gets of this process include the adipogenic zinc finger
transcription factor ZFP423, and the myogenic transcrip-
tion factor PRRX1. Activation of Zfp423 through knock-
down of Zfp521, its negative regulator, is capable of
altering mesodermal cell fate from osteogenic to lipo-
genic lineage [42]. We found increased LIFs in
Alk5Dermo1 lungs associated with increased Zfp423
mRNA. Likewise, Zfp423 increased robustly in cultured
Alk5–/– cells undergoing spontaneous LIF differentiation
(Fig. 5j). Importantly, TGFβ1 strongly repressed Zfp423,
and only in presence of functional ALK5 (Fig. 5l). Thus,
while ALK5 activity is required for αSMApos cell lineage
commitment, its inactivation de-represses Zfp423 favor-
ing early LIF lineage commitment. In support of this
conclusion, we found profoundly increased expression of
Wisp2, known to be expressed at high levels in commit-
ted adipocyte precursors. In contrast, PRRX1 is a
mesodermal transcription factor [43] that promotes dif-
ferentiation of mesenchymal precursors into αSMApos
cells. PRRX1 inhibits adipogenesis while its stable
knockdown enhances adipogenesis, as shown by in-
creased Pparγ, Cebpα, and Fabp4 expression [44]. In
Alk5Dermo1 lungs, Prrx1 decreased as Zfp423 increased,
indicating a key mechanism by which Alk5 repression fa-
cilitates LIF commitment while inhibiting αSMApos cell
differentiation.
In conclusion, these data establish that ALK5 has a
regulatory role in the control of early mesodermal pro-
genitor commitment between two alternative cell line-
ages. This role is consistent with previous in vitro
studies wherein genome-wide pathway analysis identified
members of the TGFβ superfamily as modulators of adi-
pocyte/myocyte differentiation [45]. αSMApos cell deter-
mination is regulated by TGFβ signaling and requires
further signaling by FGF9 and PDGFRα. In the wild type
multipotential mesoderm, activation of the αSMApos cell
pathway, mediated by the transcription factor PRRX1
also limits the ontogeny of LIFs. Blocking ALK5-
mediated TGFβ signaling in ALK5Dermo1 mesoderm
inhibited αSMApos cell differentiation and increased
(de-repressed) the expression of Zfp423, the key LIF
transcription factor [28]. Therefore, it appears that,
while αSMApos cell lineage is actively determined by
ALK5-mediated TGFβ signaling, LIF determination
represents a default position on a biological binary
switch. This means that LIF can be activated only




The Alk5flox/flox (C57BL6 background) and Dermo1-cre
mice were described previously [39, 46]. Pdgfraflox/flox
mice were purchased from the Jackson Laboratory.
Mesodermal progenitor specific knockout mutants,
Alk5Dermo1 (Alk5flox/flox;Dermo1-cre) or PdgfraDermo1
(Pdgfraflox/flox;Dermo1-cre) were generated by crossing
Alk5flox/flox or Pdgfraflox/flox homozygous females with
Alk5 flox/+;Dermo1-cre or Pdgfraflox/+;Dermo1-cre double
heterozygous males in a pure C57BL6 background.
Alk5flox/flox or Pdgfraflox/flox mice were used as control.
Triple transgenic Alk5flox/flox;Dermo1-cre;mTmG mice
(simply Alk5Dermo1;mTmG) were generated as previously
reported [47]. Genotyping of the Dermo1-cre mice con-
taining Alk5flox, Alk5Δ, and Alk5wt alleles was as previ-
ously described [39, 46]. All animal procedures were
performed according to approved University of Southern
California Institutional Animal Care and Use Committee
regulations.
Tissue collection and Oil Red O staining
Embryonic lungs from control and mutant lungs were
collected at various embryonic stages from E11.5 to
E18.5. The embryos or lungs were dissected and fixed
overnight in 4 % paraformaldehyde at 4 °C. They were
then dehydrated through increasing ethanol concentra-
tion and embedded in paraffin or OCT compound. Sec-
tions of 5-μm thickness were used for histological
analysis. Frozen lung sections or cultured cells were
stained with Oil Red O to detect LIFs according to the
manufacturer’s protocol (Poly Scientific, Bayshore, NY,
USA). The experiments were repeated using three mice
within each genotype group (n = 3). For raw data per-
taining to quantification of Oil Red O positive cells in
Additional file 5, please see Additional file 9.
TUNEL assay
Apoptotic cells were detected by using TUNEL detection
kit (In Situ Cell Death Detection Kit, Roche Diagnostics,
Indianapolis, IN, USA). Briefly, tissue sections were
deparaffinized, rehydrated, and washed with distilled-
deionized water. After treatment with proteinase K
(Invitrogen, Carlsbad, CA, USA), fragmented DNA was
labeled with fluorescein-dUTP, using terminal transfer-
ase (Roche Diagnostics). Slides were mounted with
VECTASHIELD containing DAPI (Vector Laboratories,
Burlingame, CA, USA). The apoptotic percentage was
obtained as previously described [12] by manual count-
ing of TUNELpos cells in groups of 4,000 or more cells.
Immunohistochemistry (IHC)
Routinely prepared histological sections were deparaffi-
nized with xylene and rehydrated through an alcohol
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gradient series to water. Antigens were retrieved and en-
dogenous peroxidase activity was quenched using 3 %
hydrogen peroxide. After normal serum blocking, the
sections were incubated with a primary antibody at 4 °C
overnight. Impress-anti-rabbit or anti-mouse or anti-
goat IgG (Vector Laboratories) were applied for 50 min
at room temperature. Staining was visualized by
Peroxidase Substrate Kit DAB (Vector Laboratories). For
immunofluorescence staining, the sections were incu-
bated with primary antibodies overnight at 4 °C. After
washing steps, the sections were reacted with a mixture
of DyLight™549-conjugated donkey anti-rabbit or anti-
mouse IgG (H + L) or DyLight™488-conjugated donkey
anti-mouse IgG or anti-goat IgG (H + L) (all from
Jackson ImmunoResearch Laboratories, Inc., West Grove,
PA, USA) for 1 h in the dark at room temperature. After
thorough rinses with PBS containing 0.1 % Triton X-100,
the sections were mounted with VECTASHIELD mount-
ing medium containing DAPI (to visualize nuclei). Pri-
mary antibodies used are described in Additional file 10.
The experiments were repeated in more than three mice
within each genotype group (n >3).
Mesenchymal cell isolation, SV40 transformation,
Fluorescence Activated Cell Sorting (FACS) and treatment
Primary mesenchymal cells were isolated by differential
adherence [48]. Briefly, fetuses were dissected from preg-
nant control and mutant mice at E15.5 or E16.5. Six
pairs of lungs were pooled for each experiment (n = 6).
Lungs were dissociated with 0.025 % trypsin/EDTA in
DMEM (Gibco) at 37 °C. The cells were filtered and
plated in 75 cm2 tissue culture flasks for 1 h, after which
the non-adherent cells were discarded. Adherent cells
were then washed and grown for 24 h. The primary cells
were subsequently transformed by SV40 infection and
subjected to FACS based on GFP activity using AriaII
(Becton Dickinson). Gates were set according to un-
stained controls. After FACS, GFPpos cells were either
plated on 6-well plates in DMEM, containing 10 % fetal
bovine serum, FBS (Gibco) for subsequent analysis, or
directly subjected to Q-PCR.
For TGFβ1 (R&D Systems, Minneapolis, MN, USA) or
Imatinib (Cayman Chemical Co. Ann Arbor, MI, USA)
treatment, the purified Alk5+/+ or Alk5–/– cells were
plated at a density of 5 × 104 cells/cm2 into 6-well tis-
sue culture plates in DMEM with 10 % FBS. Cells
were serum-starved overnight before treatment with
TGFβ1 (4 ng/mL according to the manufacturer’s
recommendation) or imatinib (5 μL and 10 μL). TGFβ
treatment was for 48 h; Imatinib treatment was for 5 days.
Controls were treated exactly the same with the exception
of BSA in place of TGFβ and DMSO in place of Imatinib.
All conditions in Fig. 6a (Control, Alk5+/+, Alk5–/–) were
initiated and analyzed after the same incubation period.
For adipogenesis differentiation, low-passage (<6
passages) Alk5+/+ and Alk5–/– cells were plated at a
density of 5 × 104 cells/cm2 in DMEM containing
10 % FBS. At 80 % confluence, old medium was aspi-
rated and replaced with fresh DMEM containing 2 %
FBS. After 2, 5, or 10 days of incubation, the cells
were stained with Oil Red O according to the manu-
facturer’s protocol (Poly Scientific, Bayshore, NY,
USA) or prepared for RNA and protein analysis. Alk5+/+
and Alk5–/– cells at 80 % confluence were used as a con-
trol. All experiments were performed in duplicate three
times (n = 3).
Western blot analysis
Total protein was extracted with RIPA buffer (Sigma, St.
Louis, MO, USA) from embryonic lung tissues or cul-
tured cells. Protein concentrations were determined by a
BCA Protein Assay kit (Thermo Scientific, Grand Island,
NY, USA); 15–30 μg of protein was loaded onto 3–8 %
NuPAGE gels and transferred to Immobilon-P mem-
branes (both from Millipore Corp, Billerica, MA, USA).
Membranes were then blocked with 5 % milk in Tris-
buffered saline and incubated with primary antibodies
overnight. The secondary antibodies, goat-anti-rabbit or
goat-anti-mouse IgG-HRP (both from Pierce, Thermo
Scientific), were applied at a 1:1000 dilution for 30 min.
Membranes were reacted with chemiluminescence re-
agent ECL (Amersham Biosciences, GE Healthcare Life
Sciences, PA, USA) and exposed to photographic film
(Amersham Hyperfilm ECL). The primary antibodies
used are described in Additional file 10.
Quantitative Polymerase Chain Reaction (Q-PCR)
DNase-free RNA was prepared using Trizol reagent
(Invitrogen) according to the manufacturer’s instruc-
tions. After DNase treatment, total RNA (2 μg) was
reverse-transcribed to cDNA using the Superscript III
First-Strand Synthesis System for RT-PCR kit (Invitrogen),
according to the manufacturer’s instructions. The
cDNA was subjected to Q-PCR using SYBR Green
PCR Master Mix with a LightCycler (Roche) as previ-
ously described [47]. Gene expression was normalized
to β-actin or Tbp. All primers for Q-PCR were de-
signed by using the program of Universal Probe Library
Assay Design Center from Roche Applied Sciences. Speci-
ficity of each PCR reaction was verified by electrophoresis
on 2 % gel.
Relative quantification analysis was carried out with
LightCycler software, Version 4 (Roche). The results
were expressed as a normalized ratio (fold). β-actin or
Tbp were used as reference genes for normalization.
Samples from control lungs served as ‘Calibrators’.
For raw data pertaining to Q-PCR studies, please see
Additional file 9.
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Statistical analysis
In total, the lungs or embryos from 98-pair Alk5Dermo1
mutant and control mice were analyzed using different
techniques. For Q-PCR and western blot analysis, most
experiments were performed two or three times, and the
samples in each experiment were analyzed in triplicates
or duplicates. All data are represented as mean ± standard
error or standard error of the mean. The significance of
differences between two sample means was determined by
the two-tailed Student t-test, which is a common and well
established statistical method to ascertain differences
between two samples. Level of significance was denoted
by P <0.05.
Availability of supporting data
Data supporting the results of this article are available in
Additional file 9.
Additional files
Additional file 1: Dermo1-cre-mediated mesodermal progenitor-specific
deletion of Alk5. A–C. Dermo1-cre expression pattern in E14.5 Dermo1-
cre;mTmG lungs. Dermo1-cre-mediated recombination (green fluorescence)
was located in the mesenchyme surrounding the trachea (A), bronchi (B),
bronchioles and blood vessels (C), not in the epithelial cells. D. Deletion of
Alk5 exon 3 by crossing Alk5flox/flox to Dermo1-cre mice. E. Deletion of Alk5
was validated by PCR with genomic DNA. F. Western blot analysis using
total protein from E16.5 control and Alk5Dermo1 lungs. n = 3. β-ACTIN was
used as a control. G–J. Immunohistochemistry for ALK5 (G and I) and PAI-1
(H and J) showed lost or decreased ALK5 and PAI-1 (Arrows in I and J) in
Alk5Dermo1 lungs. Scale bars: C, J = 20 μm. (PPTX 925 kb)
Additional file 2: Mesodermal-specific Alk5 inactivation causes pulmonary
hypoplasia. A–D. Gross morphology of E16.5 control (A and B) and
Alk5Dermo1 (C and D) lungs. E–J. PAS (E, H, G and J) and H&E (F and I) staining
of E18.5 control (E–G) and Alk5Dermo1 (H–J) lungs. Arrows in I indicate a
thicker alveolar wall in Alk5Dermo1 lungs; Arrows in J indicate robust PAS
staining in Alk5Dermo1 lungs. Scale bars: H = 100 μm; I = 10 μm, J = 20 μm.
(PPTX 1736 kb)
Additional file 3: Mesodermal Alk5 deficiency inhibits epithelial cell
differentiation and disrupts vasculogenesis. A–H. Immunohistochemistry
(IHC) for Acetylated-tubulin (A and E), CC10 (B and F), pro-SPC (C and G)
and T1a (D and H) in E18.5 control and Alk5Dermo1 lungs showing
decreased expression of the latter genes in Alk5Dermo1 lungs. I. Q-PCR
confirmed inhibition of epithelial cell markers in Alk5Dermo1 lungs, n = 2–9
pairs of separate lungs. J and L: IHC for GFP and FLK1 showing decreased
GFP+/FLK1+ cells in E14.5 Alk5Dermo1 lungs. K and M: IHC showed decreased
CD34+ cells in E14.5 Alk5Dermo1 lungs. N–Q. IHC showing decreased of
PECAM1+ cells in E18.5 Alk5Dermo1 lungs. Arrows indicate large blood
vessels appearing intact. R. Quantitative PCR confirmed decreased
Pecam1, Flk1, and Flt1 mRNAs in E13.5 mutant lungs. n = 3 pairs of
separate lungs. Error bars show standard deviation. *P <0.05. Scale
bars: H = 30 μm; M and Q = 20 μm. (PPTX 1560 kb)
Additional file 4: Quantification of sub-mesothelial mesenchyme (SMM)
size. Hematoxylin and eosin-stained lung tissue sections were prepared
and random images were collected under 40× objective from both control
and Alk5Dermo1 embryos at E12.5 and E13.5. The various dimensions
that were measured included boundaries of the SMM compartments,
as delineated on each photomicrograph, from mesothelium to the
mesenchyme wrapped around the epithelium (SEM). The regions
encompassing the SMM were measured in Photoshop by dividing
each region at random of six points to manually calculate the length
from mesothelium to SEM (μm). Sample size, n = 3 separate lung tissue
sections. Error bars show standard deviation. *P <0.05. (PPTX 75 kb)
Additional file 5: Quantification of Oil Red O storage. Lung tissue
sections from E18.5 control and Alk5Dermo1 lungs were analyzed by
staining with Oil Red O for assessment of LIF differentiation. Oil Red O
stained sections were viewed and random images were collected under
40× objective, and were analyzed by imaging using a previously
described protocol [49], n = 3. The density of Oil Red O stained cells was
then calculated and plotted as shown. Error bars show the standard
deviation. *P <0.05 (PPTX 43 kb)
Additional file 6: Quantification of smooth muscle (SM) thickness and
areas covered by smooth muscle in control and PdgfrαDermo1 lungs at
E18.5. αSMA immunohistochemical stained lung sections were collected
by random sampling using the 40× objective from three pairs of control
and PdgfrαDermo1 mutant lungs at E18.5. The thickness and coverage of
SM were quantified. A. Quantification of SM thickness. The arithmetic
mean thickness of the SM cell layer was determined by volume of
αSMApos compartment, measured by counting all points intercepting the
airway epithelium and αSMApos compartment. n = 3. B. Quantification of
SM coverage. The percentage of SM airway coverage was determined by
assessing the percentage of the airway epithelium circumference in
contact with number of αSMApos cells. n = 3. Error bars show the standard
deviation. *P <0.05 (PPTX 54 kb)
Additional file 7: Mesodermal progenitor-specific deletion of Pdgfrα.
A. Quantitative PCR (Q-PCR) showed PDGF signaling target genes are
decreased, indicating an overall functional repression of PDGFA signaling
pathway in E14.5 PdgfraDermo1 lungs. n = 2 pairs of separate lungs, repeated
twice or thrice. B. Q-PCR showed repression of myofibroblast-related genes
in PdgfraDermo1 lungs. n = 2 pairs of separate lungs, repeated thrice for each.
Error bars show SEM. (PPTX 68 kb)
Additional file 8: Mesodermal Alk5 deficiency increased cell apoptosis.
The number of TUNELpos cells as determined by previously described
methods [12]. A–D. TUNEL assay showed increased number of TUNELpos
cells in the Alk5Dermo1 lungs at E18.5. E. Quantification of the relative
number of TUNELpos cells (green) per 4,000 total cells. Error bars show
standard deviation. *P <0.05. (PPTX 794 kb)
Additional file 9: Raw data. (XLSX 247 kb)
Additional file 10: Primary antibodies used in western blots and
immunohistochemistry. (DOC 37 kb)
Abbreviations
FACS: Fluorescence Activated Cell Sorting; IHC: Immunohistochemistry;
LIF: Lipofibroblasts; PBSM: Peribronchial smooth muscle; Q-PCR: Quantitative
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mesenchyme; TGFβ: Transforming growth factor beta.
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